Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

ClinicalTrials.gov ID: NCT00929539

Public ClinicalTrials.gov record NCT00929539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety and Tolerability of JTT-130 in Treatment-naïve, Metformin Only or Metformin Plus Sulfonylurea-treated Obese Type 2 Diabetic Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.

Study identification

NCT ID
NCT00929539
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Akros Pharma Inc.
Industry
Enrollment
496 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2009 (Type not available)
Primary completion
May 2010 (Actual)
Completion
Jul 2010 (Actual)
Last update posted
Feb 4, 2013

2009 – 2010

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
48
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Muscle Shoals Alabama — —
Not listed Scottsboro Alabama — —
Not listed Tucson Arizona — —
Not listed Encino California — —
Not listed Los Angeles California — —
Not listed Sacramento California — —
Not listed Spring Valley California — —
Not listed Valley Village California — —
Not listed Walnut Creek California — —
Not listed Waterbury Connecticut — —
Not listed Delray Beach Florida — —
Not listed Hialeah Florida — —
Not listed Miami Florida — —
Not listed New Port Richey Florida — —
Not listed Ocala Florida — —
Not listed Sandy Springs Georgia — —
Not listed Chicago Illinois — —
Not listed Indianapolis Indiana — —
Not listed Erlanger Kentucky — —
Not listed Lexington Kentucky — —
Not listed Louisville Kentucky — —
Not listed Madisonville Kentucky — —
Not listed Paducah Kentucky — —
Not listed New Hyde Park New York — —
Not listed Greensboro North Carolina — —
Not listed Morehead City North Carolina — —
Not listed Statesville North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Marion Ohio — —
Not listed Tulsa Oklahoma — —
Not listed Eugene Oregon — —
Not listed Portland Oregon — —
Not listed Charleston South Carolina — —
Not listed Greer South Carolina — —
Not listed North Charleston South Carolina — —
Not listed Bristol Tennessee — —
Not listed Austin Texas — —
Not listed Corpus Christi Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed San Antonio Texas — —
Not listed Salt Lake City Utah — —
Not listed Manassas Virginia — —
Not listed Richmond Virginia — —
Not listed Bellevue Washington — —
Not listed Olympia Washington — —
Not listed Oregon Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00929539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00929539 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →